Clinical Trial Update: Pharmacokinetics & Safety of Serelaxin on Top of Standard of Care Therapy in Pediatric Patients With Acute Heart Failure [Phase 2]

View source ↗

Summary

Phase 2 trial assessing pharmacokinetics and safety of serelaxin added to standard of care in pediatric acute heart failure; the study was terminated with poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• Serelaxin (serelaxin)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Acute Heart Failure | Phase 2 | Status: TERMINATED | Results posted: 2019-06-25